Treatment Development Targeting Severe and Persistent Negative Symptoms



Status:Completed
Conditions:Schizophrenia
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 60
Updated:4/21/2016
Start Date:January 2011
End Date:January 2015

Use our guide to learn which trials are right for you!

People with schizophrenia often have problems with negative symptoms; expressing and
identifying their emotions, their amount of speech, motivation and interests, feelings of
purpose, social skills, and experiencing enjoyment. For this reason, new interventions are
being developed to treat these problems. One new intervention is the Motivation and
Engagement (MOVE) Program. The MOVE program is a new program which consists of weekly
meetings for 9 months between a patient and a trainer. The weekly meetings will consist of
goal setting and organization of the home to make daily tasks more manageable. During the
weekly meetings the patient and trainer will discuss emotions and the trainer will help the
patient identify their emotions.

The researchers hope to learn whether MOVE will help improve the problems. If it works the
researchers will do a larger study comparing MOVE to other treatments that have addressed
some of the problems already.

The therapist will ask you if the sessions can be audio taped to ensure that the therapist
is doing a helpful job for you. They will also ask if the session can be video taped so that
the tapes can be used to train other therapists learning about MOVE. The choice to do either
of these is voluntary and you can continue to participate in the study if you choose not to
have the session be audio and/or video taped.You will be provided a University Release
document to provide that permission if you so choose.


Inclusion Criteria:

1. Male or female between the 18-60 who meet DSM-IV criteria for schizophrenia confirmed
by the Structured Clinical Interview Diagnosis (SCID-P version). Outpatient status.

2. Receiving treatment with antipsychotic medication

3. Clinically stable for a minimum of 5 months prior to screening (no significant
changes in schizophrenia symptomatology, depressive symptoms, or community
functioning, no hospitalizations, emergency visits or incarceration due to symptoms
of schizophrenia or depression, no medication increases due to symptom exacerbation)

4. Has clinically meaningful negative symptoms as indicted by a score of 4 or higher on
at least 2 of 6 of the following symptom domains as rated by the NSA-16; restricted
affect, diminished emotional range, poverty of speech, curbing of interest,
diminished sense of purpose, and diminished social drive

5. No more than moderate positive symptoms as indicated by a score of 5 or lower on
BPRS-E items measuring delusions and hallucinations and no more than a 4 or higher on
conceptual disorganization

6. No more than mild depression as indicated by a score of 3 or lower on the BPRS

7. No significant movement disorder as indicated by a score of 3 or lower on the ESRS-A

8. Able to provide evidence of a stable living environment (individual apartment, family
home, board and care facility with no plans to move in the next year)

Exclusion Criteria:

1. History of significant head trauma

2. History of a seizure disorder

3. Mental Retardation

4. Alcohol or drug abuse or dependence within the past 3 months

5. History of violence in the past one year
We found this trial at
1
site
San Antonio, Texas 78207
?
mi
from
San Antonio, TX
Click here to add this to my saved trials